Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.23.2
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Revenue
Operating expenses        
Research and development 1,379,567 633,250 3,207,474 2,294,071
General and administrative 368,259 140,057 781,434 468,439
Total operating expenses 1,747,826 773,307 3,988,908 2,762,510
Loss from operations (1,747,826) (773,307) (3,988,908) (2,762,510)
Interest Income 119,453 27,234 235,633 46,809
Net loss $ (1,628,373) $ (746,073) $ (3,753,275) $ (2,715,701)
Per share information:        
Net loss per common share, basic $ (0.13) $ (0.06) $ (0.29) $ (0.21)
Net loss per common share, diluted $ (0.13) $ (0.06) $ (0.29) $ (0.21)
Weighted average common shares outstanding, basic 12,848,165 12,923,434 12,848,165 13,091,915
Weighted average common shares outstanding, diluted 12,848,165 12,923,434 12,848,165 13,091,915